医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Half-dry ‘Gold Tongue Sole’ of Ariul Fish Becomes Popular as Home-cooked Dish to Make a Table Great

2020年12月22日 PM06:12
このエントリーをはてなブックマークに追加


 

SEOUL, South Korea

‘Gold Tongue Sole’, a half-dry fish product of Korea’s Ariul Fish LLC, is popular among working moms who prefer simple and easy to prepare meals due to busy life.

They are hesitant to go to restaurants due to the COVID-19 pandemic and face difficulty in deciding the menu for preparing meals at home every day.

Half-dry ‘gold tongue soles’ from Ariul Fish turn into an attractive main dish when their front and rear sides are yellowly grilled in an oiled pan. Containing less moisture as they are dried after removing innards, half-dry fishes are free from burning and take a shorter time in cooking. As they are properly salted, it is not needed to add salt.

Being caught mainly on the west coast of Gunsan, Jeollabuk-do in Korea, tongue soles are flat fishes that belong to the red tongue sole family. It contains a variety of nutrients, such as protein and minerals, with less smell and a fresh taste.

“Containing plenty of calcium and ingredients that help the absorption of calcium as well as iron, tongue soles help people prevent osteoporosis and enhance the health of bone,” said a manager at Ariul Fish. “As it is effective in numerous aspects, intake of tongue sole will be beneficial in winter when nutrients may be insufficient.”

In 2012, Ariul Fish registered ‘Love Sea-Gold Tongue Sole’ as a trademark with the Korean Intellectual Property Office. Having obtained the HACCP certification and selected as the Clean Factory by the Korea Gov., the company is assuredly focusing on quality management.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201222005234/en/

CONTACT

Ariul Fish LLC

Hyeon-gu Jeong

+82-63-443-3313

pko3313@naver.com

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • ERS Genomicsと日本エスエルシーがCRISPR/Cas9ライセンス契約に署名
  • Mirum Pharmaceuticals and GC Pharma Enter into Exclusive Licensing Agreement to Develop and Commercialize Maralixibat for Rare Liver Diseases in South Korea
  • Dr. Revati Shreeniwas Joins ImmunoMet Therapeutics as Chief Medical Officer
  • Adagio Therapeutics Partners with Biocon Biologics to Bring Potent and Broadly Neutralizing COVID-19 Antibody Treatment to Patients in India and Select Emerging Markets
  • Twist Bioscience社がMOLCURE社の人工知能技術を導入し、抗体医薬品の探索を強化